Chagasic Meningoencephalitis in a patient as the initial presentation of HIV infection

Authors

DOI:

https://doi.org/10.53732/rccsalud/e8905

Keywords:

trypanosoma cruzi, HIV, Chagas disease reactivation, benznidazole

Abstract

A 57-year-old male farmer consults our hospital with a 30-day history of fever, weight loss, asthenia, anorexia. 48 hours before admission he presented incoherent speech. Upon admission the patient presented marked protein-calorie malnutrition, Glasgow 13/15, psychomotor excitation, CSF protein 907 mg/dl, glucose 30 mg/dl, leukocytes 16 cells/field with mononuclear predominance. Analysis of cerebrospinal fluid (CSF), direct examination showed trypomastigotes of Trypanosoma cruzi. Peripheral blood smear: hemoparasite compatible with Trypanosoma cruzi was observed. HIV serology (+), CD4 92, viral load 1,672,532 copies. The patient was treated with 5 mg/kg/day of beznidazole, received prophylaxis with TMS-SMS, azithromycin for advanced immunosuppression, and antiretroviral therapy. On day 10 of treatment, he developed a generalized skin rash, interpreted as an adverse effect of treatment. Beznidazole and trimethoprim sulfa were discontinued. Family members requested discharge. The patient's progress is unknown.

Downloads

Download data is not yet available.

References

Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis. 2009;9(5):324-30. https://doi.org/10.1016/S1473-3099(09)70088-X

Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388-402. https://doi.org/10.1016/S0140-6736(10)60061-X

Bisio M, Altcheh J, Lattner J, Moscatelli G, Fink V, Burgos JM, et al. Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS. Emerg Infect Dis. 2013;19(9):1490-2. https://doi.org/10.3201/eid1909.130667

França LC. Tumour-like chagasic encephalitis in AIDS patients. Arq Neuropsiquiatr. 2009;67(2A):368. https://doi.org/10.1590/s0004-282x2009000200043

Lambert N, Mehta B, Walters R, Eron JJ. Chagasic encephalitis as the initial manifestation of AIDS. Ann Intern Med. 2006;144(12):941-3. https://doi.org/10.7326/0003-4819-144-12-200606200-00018

Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes-Araújo FR, Rocha A. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis. 1997;25(6):1397-400. https://doi.org/10.1086/516130

Madalosso G, Pellini AC, Vasconcelos MJ, Ribeiro AF, Weissmann L, et al. Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil. Rev Inst Med Trop Sao Paulo. 2004;46(4):199-202. https://doi.org/10.1590/s0036-46652004000400005

Buccheri R, Kassab MJ, Freitas VL, Vicente da Silva SC, Bezerra RC, Khoury Z, et al. Chagasic meningoencephalitis in an hiv infected patient with moderate immunosuppression: prolonged survival and challenges in the haart era. Rev Inst Med Trop Sao Paulo. 2015;57(6):531-535. https://doi.org/10.1590/S0036-46652015000600014

Garzón-Hernández JP, Pabón-Moreno A, González-Vesga RE, Uribe-Rodríguez LG, Silva-Sieger FA. Chagasic meningoencephalitis after heart transplant. IDCases. 2021;26:e01353. https://doi.org/10.1016/j.idcr.2021.e01353

Multani A, Meer A, Smith DS, Kheraj MN, Plowey ED, Blackburn B. Diagnosis of Chagasic Encephalitis by Sequencing of 28S rRNA Gene. Emerg Infect Dis. 2019;25(7):1370-1372. https://doi.org/10.3201/eid2507.180285

Fernández ML, Marson ME, Mastrantonio GE, Corti MA, Fleitas U, et al. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients. Antimicrob Agents Chemother. 2021;65(3):e01922-20. https://doi.org/10.1128/AAC.01922-20

Silva HFLD, Miranda LFF, Oliveira MDS, Saraiva PPG, Nakata RZ, et al. Cianca RP. Trypanosoma cruzi (DTU TcI) in a fatal case of meningoencephalitis due to Chagas disease reactivation in a patient coinfected with human immunodeficiency virus: case report. Rev. Soc. Bras. Med. Trop. 2025;58:e02342025. https://doi.org/10.1590/0037-8682-0234-2024

Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, Sousa ASd, Sartori AMC, Santana RC, et al. Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the “Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions”. PLoS Negl Trop Dis. 2023;17(1):e0011036. https://doi.org/10.1371/journal.pntd.0011036

Useche Y, Pérez AR, de Meis J, Bonomo A, Savino W. Central nervous system commitment in Chagas disease. Front Immunol. 2022;13:975106. https://doi.org/10.3389/fimmu.2022.975106

Hoem EL, Kvalvik T, Dyrhovden R, Helland IE, Blomberg B, Mørch K. A woman in her seventies with fever and convulsions. Tidsskr Nor Laegeforen. 2024;144(6). https://doi.org/10.4045/tidsskr.23.0444

Published

2026-02-28

How to Cite

1.
Chagasic Meningoencephalitis in a patient as the initial presentation of HIV infection. Rev. cient. cienc. salud [Internet]. 2026 Feb. 28 [cited 2026 Jun. 25];8:01-5. Available from: http://www.upacifico.edu.py:8040/index.php/PublicacionesUP_Salud/article/view/905